MRM’s platform could optimise the link between the gut microbiome and cancer outcomes
Category: Oncology
The candidate is being evaluated as both a monotherapy and in combination pembrolizumab
The alliance combines Lumanity’s commercial and development strategy capabilities with PICI’s translational research expertise
The UK National Institute for Health and Care Excellence has recommended a targeted twice daily drug treatment that […]
The model could lead to more targeted treatments for the disease
What is Enhertu?Trastuzumab deruxtecan (Enhertu), made by Daiichi Sankyo and AstraZeneca, is a treatment for adult patients with […]
The rogue breast surgeon Ian Paterson has told a coroner’s court that he did not seek specific consent […]
NHS England is piloting a new device that can be attached to a smartphone to enable nurses to […]
The company’s workforce will volunteer and fundraise for Team Jak throughout the year
